Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial

Alparslan Turan(Outcomes Research Consortium), Syed Atif Raza, Paul C. Fitzgerald(Northwestern University), Praneeta Chodavarapu, Sergio D. Bergese(Stony Brook University Hospital), Kurt Ruetzler(Outcomes Research Consortium), Carlos Trombetta(Cleveland Clinic), Chetan Lokhande, Daniel I. Sessler(Outcomes Research Consortium), Jennifer Hargrave(Cleveland Clinic), Zohaib Akhtar, Gildasio De Oliveira, Kimberly Howard‐Quijano(University of Pittsburgh Medical Center), Guangmei Mao(University of Michigan), Gausan Ratna Bajracharya, Jonathan Fang(Henry Ford Health System), Evis Cuko, Matthew T. Hutcherson, Andra E. Duncan(Cleveland Clinic), Andrew J. Feider(University of Iowa Hospitals and Clinics), Hassan Hamadnalla(Cleveland Clinic), Dilara Khoshknabi, Quinton Riter(Cleveland Clinic), Nika Karimi(University of Rochester), Hooman Honar, Manal Salah Hassan(Cleveland Clinic), Azfar Niazi, Mohammad Zafeer Khan, Logan Glosse, Kavita Elliott, Marc Gillinov(Cleveland Clinic), Steve Leung(MetroHealth), Sabry Ayad(Cleveland Clinic), Partha Saha, Seyhan Yağar
The Lancet
July 1, 2020
Cited by 303


Related Papers